3-METHYL-4-(4-METHYLPIPERAZIN-1-YL)ANILINE, 95%, 100mg

Lithium chloride, min. 98.5%, pure, 1 kg, plastic packaging.

3,4,8,9,10,11-hexahydro-2H-cyclohepta[3,4]pyrrolo[1,2-a]pyrazin-1(7H)-one, 98%, 500mg

(4-Chloro-1-methyl-1H-pyrazol-5-yl)methylamine hydrochloride, 95.0%, 100mg

Buffer solution pH 10.00 ±0.01 (20 °C), ROTI®Star, 500 ml, plastic packaging.

((3aR,4R,6R,6aR)-6-Methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate, 95.0%, 1g

Ethyl 2-chloro-5-methylnicotinate, 95.0%, 250mg

3-(5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzoic acid, 95.0%, 100mg

(E)-3-(1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylic acid, 250mg

(5,6-Dimethyl-thieno[2,3- d ]pyrimidin-4-ylsulfanyl)-acetic acid, 1g

(S)-2-(4-Methylphenylsulfonamido)pentanedioic acid, 95.0%, 5g

2-Chloro-4-hydroxybenzaldehyde, 97.0%, 5g

2-Chloro-5-trifluoromethylbenzenethiol, 1g